168 related articles for article (PubMed ID: 29855783)
1. Is serum TSH a biomarker of thyroid carcinoma in patients residing in a mildly iodine-deficient area?
Swan KZ; Nielsen VE; Godballe C; Thrane JF; Mortensen MR; Schytte S; Pedersen HB; Christiansen P; Bonnema SJ
Endocrine; 2018 Aug; 61(2):308-316. PubMed ID: 29855783
[TBL] [Abstract][Full Text] [Related]
2. Preoperative TSH level and risk of thyroid cancer in patients with nodular thyroid disease: nodule size contribution.
Zafón C; Obiols G; Mesa J
Endocrinol Nutr; 2015 Jan; 62(1):24-8. PubMed ID: 25066642
[TBL] [Abstract][Full Text] [Related]
3. [Association between the serum TSH concentration and thyroid cancer incidence].
Li JZ; Jin YJ; Liu X; Zhang LY
Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):921-4. PubMed ID: 22340102
[TBL] [Abstract][Full Text] [Related]
4. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration.
Boelaert K; Horacek J; Holder RL; Watkinson JC; Sheppard MC; Franklyn JA
J Clin Endocrinol Metab; 2006 Nov; 91(11):4295-301. PubMed ID: 16868053
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of serum thyrotropin for risk prediction of differentiated thyroid cancers does not apply to microcarcinomas: results of 1,870 Chinese patients with thyroid nodules.
Shi L; Li Y; Guan H; Li C; Shi L; Shan Z; Teng W
Endocr J; 2012; 59(11):973-80. PubMed ID: 22785429
[TBL] [Abstract][Full Text] [Related]
6. Higher TSH level is a risk factor for differentiated thyroid cancer.
Kim HK; Yoon JH; Kim SJ; Cho JS; Kweon SS; Kang HC
Clin Endocrinol (Oxf); 2013 Mar; 78(3):472-7. PubMed ID: 22924613
[TBL] [Abstract][Full Text] [Related]
7. The Danish investigation on iodine intake and thyroid disease, DanThyr: status and perspectives.
Laurberg P; Jørgensen T; Perrild H; Ovesen L; Knudsen N; Pedersen IB; Rasmussen LB; Carlé A; Vejbjerg P
Eur J Endocrinol; 2006 Aug; 155(2):219-28. PubMed ID: 16868134
[TBL] [Abstract][Full Text] [Related]
8. Dynamic profile of differentiated thyroid cancer in male and female patients with thyroidectomy during 2000-2013 in China: a retrospective study.
Yan HX; Pang P; Wang FL; Tian W; Luo YK; Huang W; Yang GQ; Jin N; Zang L; Du J; Ba JM; Dou JT; Mu YM; Lyu ZH
Sci Rep; 2017 Nov; 7(1):15832. PubMed ID: 29158505
[TBL] [Abstract][Full Text] [Related]
9. Searching for the most effective thyrotropin (TSH) threshold to rule-out autonomously functioning thyroid nodules in iodine deficient regions.
Giovanella L; D'Aurizio F; Campenni' A; Ruggeri RM; Baldari S; Verburg FA; Trimboli P; Ceriani L
Endocrine; 2016 Dec; 54(3):757-761. PubMed ID: 27628737
[TBL] [Abstract][Full Text] [Related]
10. High Serum Thyrotropin Concentrations within the Reference Range: A Predictor of Malignancy in Nodular Thyroid Disease.
Duccini K; de Souza MVL; Delfim R; Aguiar AP; Teixeira P; Vaisman M
Med Princ Pract; 2018; 27(3):272-277. PubMed ID: 29514150
[TBL] [Abstract][Full Text] [Related]
11. Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage.
Haymart MR; Repplinger DJ; Leverson GE; Elson DF; Sippel RS; Jaume JC; Chen H
J Clin Endocrinol Metab; 2008 Mar; 93(3):809-14. PubMed ID: 18160464
[TBL] [Abstract][Full Text] [Related]
12. Determinants of TSH change in a community-based cohort.
Sigurd LB
Dan Med J; 2016 Jan; 63(1):B5196. PubMed ID: 26726909
[TBL] [Abstract][Full Text] [Related]
13. Higher TSH Is Not Associated With Thyroid Cancer Risk in the Presence of Thyroid Autoimmunity.
Paparodis RD; Bantouna D; Karvounis E; Imam S; Jaume JC
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32391913
[TBL] [Abstract][Full Text] [Related]
14. An elevated level of TSH might be predictive of differentiated thyroid cancer.
Dorange A; Triau S; Mucci-Hennekinne S; Bizon A; Laboureau-Soares S; Illouz F; Rodien P; Rohmer V
Ann Endocrinol (Paris); 2011 Dec; 72(6):513-21. PubMed ID: 22115282
[TBL] [Abstract][Full Text] [Related]
15. Predictors of change in serum TSH after iodine fortification: an 11-year follow-up to the DanThyr study.
Bjergved L; Jørgensen T; Perrild H; Carlé A; Cerqueira C; Krejbjerg A; Laurberg P; Ovesen L; Bülow Pedersen I; Banke RL; Knudsen N
J Clin Endocrinol Metab; 2012 Nov; 97(11):4022-9. PubMed ID: 22962423
[TBL] [Abstract][Full Text] [Related]
16. Is the incidence of differentiated thyroid cancer increased in patients with thyrotropin-secreting adenomas? Report of three cases from a large consecutive series.
Perticone F; Pigliaru F; Mariotti S; Deiana L; Furlani L; Mortini P; Losa M
Thyroid; 2015 Apr; 25(4):417-24. PubMed ID: 25647054
[TBL] [Abstract][Full Text] [Related]
17. Serum thyrotropin level of 30 μIU/mL is inadequate for preablative thyroglobulin to serve as a prognostic marker for differentiated thyroid cancer.
Zhao T; Liang J; Guo Z; Li J; Lin Y
Endocrine; 2016 Jul; 53(1):166-73. PubMed ID: 26782372
[TBL] [Abstract][Full Text] [Related]
18. NT-proBNP is increased in differentiated thyroid carcinoma patients and may predict cardiovascular risk.
Klein Hesselink EN; van der Horst-Schrivers ANA; van der Horst ICC; Bakker SJL; Muller Kobold AC; Brouwers AH; de Bock GH; Gietema JA; Dullaart RPF; Links TP; Lefrandt JD
Clin Biochem; 2017 Aug; 50(12):696-702. PubMed ID: 28242284
[TBL] [Abstract][Full Text] [Related]
19. Long-term cardiovascular mortality in patients with differentiated thyroid carcinoma: an observational study.
Klein Hesselink EN; Klein Hesselink MS; de Bock GH; Gansevoort RT; Bakker SJ; Vredeveld EJ; van der Horst-Schrivers AN; van der Horst IC; Kamphuisen PW; Plukker JT; Links TP; Lefrandt JD
J Clin Oncol; 2013 Nov; 31(32):4046-53. PubMed ID: 24101052
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological correlation of serum TSH in patients with thyroid nodule.
Mondal HP; Sen S; Sasmal S; Ghosal PK; Mukhopadhyay SK; Mukhopadhyay M
J Indian Med Assoc; 2011 May; 109(5):330, 335, 338. PubMed ID: 22187768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
